Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Otsuka Beijing Research Institute

Clinical trials sponsored by Otsuka Beijing Research Institute, explained in plain language.

Now part of Otsuka Holdings Co., Ltd. 4578 TOKYO

A research arm of Otsuka, a Japanese pharmaceutical company.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 3

Could a pill replace IV therapy for MDS? new study investigates

Disease control Ongoing

This study compares an oral drug (ASTX727) to an intravenous (IV) drug (decitabine) in 72 Chinese adults with myelodysplastic syndromes (MDS), a bone marrow disorder. Participants will receive both treatments in a crossover design to see if the pill works as well as the infusion.…

Phase: PHASE1, PHASE2 • Sponsor: Otsuka Beijing Research Institute • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC